Literature DB >> 26798733

Development of Mega-Aorta Following Incompletely Treated Giant Cell Arteritis.

Darwin Eton1, Atman P Shah2, Aurelie Merlo3, Karin Dill4, Mark J Russo.   

Abstract

An 82-year-old male presented with a 9.3 cm ascending aorta and arch aneurysm with additional aneurysms of the innominate, right subclavian, and left common carotid arteries. The patient had a history of temporal arteritis that was only briefly treated in 1989 and a 6 cm ascending aortic aneurysm that was repaired in 1993. Our operative strategy was to construct a temporary parallel cerebrovascular circuit for cerebral protection during the redo-sternotomy and aortic arch reconstruction, with the added benefit of permanently excluding the branch arch vessel aneurysms. Pathological analysis of the aortic specimen at the first operation may have identified giant cell arteritis, prompting medical therapy against further disease progression.

Entities:  

Keywords:  Aortic aneurysm; Carotid artery; Inflammation; Subclavian artery

Year:  2014        PMID: 26798733      PMCID: PMC4682727          DOI: 10.12945/j.aorta.2014.13-048

Source DB:  PubMed          Journal:  Aorta (Stamford)        ISSN: 2325-4637


  4 in total

Review 1.  Progress in gerontology: polymyalgia rheumatica and temporal arteritis.

Authors:  J S Goodwin
Journal:  J Am Geriatr Soc       Date:  1992-05       Impact factor: 5.562

Review 2.  Five clinical conundrums in the management of giant cell arteritis.

Authors:  Maria C Cid; Ana García-Martínez; Ester Lozano; Georgina Espígol-Frigolé; José Hernández-Rodríguez
Journal:  Rheum Dis Clin North Am       Date:  2007-11       Impact factor: 2.670

3.  The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern.

Authors:  C Salvarani; S E Gabriel; W M O'Fallon; G G Hunder
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

4.  Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis.

Authors:  Ann W Morgan; Jim I Robinson; Jennifer H Barrett; Javier Martin; Amy Walker; Sarah J Babbage; William E R Ollier; Miguel A Gonzalez-Gay; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.